Literature DB >> 15324812

Targeting apoptosis via chemical design: inhibition of bid-induced cell death by small organic molecules.

Barbara Becattini1, Sina Sareth, Dayong Zhai, Kevin J Crowell, Marilisa Leone, John C Reed, Maurizio Pellecchia.   

Abstract

Bid is a key member of the Bcl-2 family proteins involved in the control of the apoptotic cascade in cells, leading to cell death. Uncontrolled cell death is associated with several human pathologies, such as neurodegenerative diseases and ischemic injuries. Therefore, Bid represents a potential yet unexplored and challenging target for strategies aimed at the development of therapeutic agents. Here we show that a multidisciplinary NMR-based approach that we named SAR by ILOEs (structure activity relationships by interligand nuclear Overhauser effect) allowed us to rationally design a series of 4-phenylsulfanyl-phenylamine derivatives that are capable of occupying a deep hydrophobic crevice on the surface of Bid. These compounds represent the first antiapoptotic small molecules targeting a Bcl-2 protein as shown by their ability to inhibit tBid-induced SMAC release, caspase-3 activation, and cell death.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15324812     DOI: 10.1016/j.chembiol.2004.05.022

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  35 in total

1.  Apoptosis-inducing factor (AIF) is targeted in IFN-α2a-induced Bid-mediated apoptosis through Bak activation in ovarian cancer cells.

Authors:  Kotaro Miyake; Joseph Bekisz; Tongmao Zhao; Christopher R Clark; Kathryn C Zoon
Journal:  Biochim Biophys Acta       Date:  2012-06-07

Review 2.  Role of Bcl-2 family proteins and caspases in the regulation of apoptosis.

Authors:  Mohammad Shamsul Ola; Mohd Nawaz; Haseeb Ahsan
Journal:  Mol Cell Biochem       Date:  2011-01-06       Impact factor: 3.396

3.  Pharmacological manipulation of Bcl-2 family members to control cell death.

Authors:  Anthony Letai
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

4.  Development of molecular probes for second-site screening and design of protein tyrosine phosphatase inhibitors.

Authors:  Jesus Vazquez; Lutz Tautz; Jennifer J Ryan; Kristiina Vuori; Tomas Mustelin; Maurizio Pellecchia
Journal:  J Med Chem       Date:  2007-03-30       Impact factor: 7.446

5.  Development of paramagnetic probes for molecular recognition studies in protein kinases.

Authors:  Jesus Vazquez; Surya K De; Li-Hsing Chen; Megan Riel-Mehan; Aras Emdadi; Jason Cellitti; John L Stebbins; Michele F Rega; Maurizio Pellecchia
Journal:  J Med Chem       Date:  2008-06-26       Impact factor: 7.446

6.  Death pathways associated with photodynamic therapy.

Authors:  David Kessel
Journal:  Med Laser Appl       Date:  2006-11-15

Review 7.  Perspectives on NMR in drug discovery: a technique comes of age.

Authors:  Maurizio Pellecchia; Ivano Bertini; David Cowburn; Claudio Dalvit; Ernest Giralt; Wolfgang Jahnke; Thomas L James; Steve W Homans; Horst Kessler; Claudio Luchinat; Bernd Meyer; Hartmut Oschkinat; Jeff Peng; Harald Schwalbe; Gregg Siegal
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

8.  Discovery of Highly Potent 2-Sulfonyl-Pyrimidinyl Derivatives for Apoptosis Inhibition and Ischemia Treatment.

Authors:  Li Li; Xian Jiang; Shaoqiang Huang; Zhengxin Ying; Zhaolan Zhang; Chenjie Pan; Sisi Li; Xiaodong Wang; Zhiyuan Zhang
Journal:  ACS Med Chem Lett       Date:  2017-03-01       Impact factor: 4.345

9.  Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins.

Authors:  Dayong Zhai; Chaofang Jin; Chung-Wai Shiau; Shinichi Kitada; Arnold C Satterthwait; John C Reed
Journal:  Mol Cancer Ther       Date:  2008-06       Impact factor: 6.261

10.  Bid regulates the pathogenesis of neurotropic reovirus.

Authors:  Pranav Danthi; Andrea J Pruijssers; Angela K Berger; Geoffrey H Holm; Sandra S Zinkel; Terence S Dermody
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.